Seven studies evaluated the relationship between PROMs and TTP episode characteristics (number of TTP episodes, neurological symptoms, number of therapeutic plasma exchange [TPE] procedures, ADAMTS13 activity during remission, and abnormal magnetic resonance imaging [MRI]). The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.